financial results
Genetron Health Q3 Revenues up 36 Percent, Firm Announces AstraZeneca MRD Partnership
The company saw the largest increase in its IVD business, driven by sales of the S5 sequencing instrument and its 8-gene Lung Cancer Assay.
Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business
Given its dwindling cash position, the firm will phase out its COVID-19 testing business and streamline its footprint, resulting in up to €15 million in cost savings per year.
Seegene Posts 7 Percent Decline in Q3 Revenues Due to Reduction in COVID Testing
Higher sales of the South Korean firm's PCR equipment in the quarter were more than offset by a drop in revenues from its COVID-19 testing reagents.
Agilent Q4 Revenues Rise 12 Percent
Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter.
Newly Public Lucid Diagnostics Posts $200K in Preliminary Q3 Revenues
The company's revenues were derived from its EsoGuard Esophageal DNA Test for esophageal cancer and related cell-collection device.
Nov 16, 2021
Burning Rock Q3 Revenues Inch up 2 Percent
Nov 15, 2021
Sema4 Q3 Revenues Rise 12 Percent
Nov 12, 2021
Meridian Bioscience Q4 Revenues Climb 19 Percent
Nov 12, 2021
OpGen Q3 Revenues Climb 9 Percent
Nov 11, 2021
Lucira Health Posts $15M in Q3 Revenues
Nov 11, 2021
Interpace Biosciences Q3 Revenues Rise 15 Percent
Nov 10, 2021
Exagen Q3 Revenues Rise 14 Percent
Nov 10, 2021
Sophia Genetics Q3 Revenues Increase 44 Percent
Nov 10, 2021
Aspira Women's Health Q3 Revenues Up 34 Percent
Nov 9, 2021
Sera Prognostics Revenues, Net Loss Up in Q3
Nov 9, 2021
Veracyte Q3 Revenues Nearly Double
Nov 9, 2021